跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
臺北醫學大學癌症轉譯研究中心
臺北醫學大學
電話
+886-2-27361661
電子郵件
[email protected]
網站
http://my2.tmu.edu.tw/site/cancer_research
郵寄地址
在地圖上顯示
概覽
指紋
網路
專家檔案
(37)
專案
(549)
研究成果
(4321)
資料集
(242)
指紋
查看啟用 臺北醫學大學癌症轉譯研究中心 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Neoplasm
63%
Colorectal Cancer
34%
Mouse
34%
Breast Cancer
34%
Disease
33%
Liver Cell Carcinoma
29%
Prostate Cancer
25%
Epidermal Growth Factor Receptor
21%
Lung Cancer
21%
Glioblastoma
19%
Cohort Study
19%
Chemotherapy
18%
Cytotoxicity
16%
Cancer Growth
16%
Tumor Growth
15%
IC50
15%
Reactive Oxygen Metabolite
15%
Randomized Controlled Trial
15%
Colon Cancer
14%
Metastasis
14%
Inflammation
14%
Biological Marker
13%
Phosphotransferase
13%
Non Small Cell Lung Cancer
13%
Protein P53
13%
Drug Resistance
12%
Nanoparticle
11%
Carcinogenesis
11%
Anticarcinogen
11%
microRNA
10%
Western Blot
10%
Histone Deacetylase Inhibitor
9%
Small Interfering RNA
9%
Cisplatin
9%
Mitogen Activated Protein Kinase
9%
Tubulin
9%
Cytokine
9%
Combination Therapy
9%
Mouth Cancer
9%
Integrin
8%
Caspase 3
8%
Lung Adenocarcinoma
8%
Overall Survival
8%
Nuclear Factor
8%
Temozolomide
8%
Recurrent Disease
8%
Traumatic Brain Injury
8%
Adverse Event
8%
Lipopolysaccharide
8%
Histone Deacetylase
8%
Cyclooxygenase 2
8%
Cell Viability
7%
Mitogen Activated Protein Kinase 3
7%
Pancreas Cancer
7%
Antioxidant
7%
Nitric Oxide
7%
Chronic Obstructive Lung Disease
7%
Caspase
7%
Pharmacokinetics
7%
Triple Negative Breast Cancer
7%
Injury
7%
Histone Deacetylase 6
7%
Ovary Cancer
7%
Resveratrol
7%
Thyroid Hormone
7%
Antitumor Activity
7%
Infection
6%
Tumor Necrosis Factor
6%
Doxorubicin
6%
Androgen Receptor
6%
Androgen
6%
Stomach Cancer
6%
Alternative Complement Pathway C3 C5 Convertase
6%
Mouse Model
6%
Catenin
6%
Survival Rate
6%
Hypoxia
6%
Clinical Trial
6%
Diabetes Mellitus
6%
Receptor
6%
Nicotinic Receptor
5%
Sorafenib
5%
Thrombin
5%
Paclitaxel
5%
Transforming Growth Factor
5%
Anti-Inflammatory Drug
5%
Mouth Squamous Cell Carcinoma
5%
Hydrogen Peroxide
5%
Solid Malignant Neoplasm
5%
Chronic Kidney Failure
5%
Acute Myeloid Leukemia
5%
Bladder Cancer
5%
Prevalence
5%
Observational Study
5%
Brain Ischemia
5%
Hydroxamic Acid
5%
Medicine and Dentistry
Neoplasm
40%
Malignant Neoplasm
40%
Cancer Cell
36%
Breast Cancer
35%
Meta-Analysis
32%
Metastatic Carcinoma
24%
In Vitro
20%
Systematic Review
20%
Hepatocellular Carcinoma
19%
Prostate Cancer
19%
Colorectal Cancer
19%
Disease
18%
Randomized Controlled Trial
18%
Programmed Cell Death
17%
Cohort Analysis
17%
Biological Marker
15%
Lung Cancer
14%
Radiation Therapy
12%
Signal Transduction
11%
Hazard Ratio
11%
Cancer Growth
10%
Epidermal Growth Factor Receptor
10%
Cancer
10%
Glioblastoma
10%
Gene Expression
9%
Odds Ratio
9%
Overall Survival
9%
Oral Cancer
9%
Carcinogenesis
8%
Tumor Progression
8%
Recurrent Disease
8%
Cell Proliferation
8%
Autophagy
8%
Tumor Cell
7%
Cell Migration
7%
Mesenchymal-Epithelial Transition
7%
Non Small Cell Lung Cancer
7%
Triple Negative Breast Cancer
7%
Cancer Therapy
7%
Cancer Stem Cell
7%
Survival Rate
7%
Ovarian Cancer
7%
Mesenchymal Stem Cell
7%
Carcinoma Cell
6%
Traumatic Brain Injury
6%
Apoplexy
6%
Injury
6%
Nasopharynx Carcinoma
6%
Cytotoxicity
6%
microRNA
6%
Upregulation
6%
Surgery
6%
Magnetic Resonance Imaging
5%
Diabetes Mellitus
5%
Symptom
5%
Lung Adenocarcinoma
5%
Mouth Squamous Cell Carcinoma
5%
Methylation
5%
Protein Expression
5%
Cell Death
5%
Androgen Receptor
5%
Brain Ischemia
5%
Rectum Cancer
5%
Proportional Hazards Model
5%
COVID-19
5%
Stem Cell
5%
Reactive Oxygen Species
5%
Screening
5%
Xenograft
5%
Protein P53
5%
down Regulation
5%
Drug Resistance
5%
Bone Metastasis
5%
Tumor Microenvironment
5%
Phosphotransferase
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
76%
Mouse
20%
Gene Expression
18%
MicroRNA
17%
Signal Transduction
17%
Cell Proliferation
15%
Epidermal Growth Factor Receptor
15%
Carcinogenesis
14%
Mesenchymal-Epithelial Transition
14%
Colon
13%
Messenger RNA
13%
Upregulation
13%
Tumor Progression
13%
Promoter Region
12%
Anticancer
12%
Eicosanoid Receptor
12%
Stem Cell
12%
Drug Resistance
12%
Autophagy
12%
Catenin
12%
Cohort Study
11%
Cell Migration
11%
down Regulation
11%
Single-Nucleotide Polymorphism
11%
Phosphotransferase
11%
Kinase
11%
P53
10%
Cancer Stem Cell
10%
Fibroblast
10%
Integrin
10%
Methylation
9%
Protein Expression
9%
Overall Survival
9%
Genotyping
9%
Thyroid Hormone
8%
Cell Growth
8%
Cytotoxicity
7%
Survival Rate
7%
Macrophage
7%
Angiogenesis
7%
Western Blot
7%
Genetics
7%
Oxidative Stress
7%
Antineoplastic Activity
7%
Cell Cycle
6%
Ribonucleotide Reductase
6%
Epigenetics
6%
RNA
6%
DNA Methylation
6%
Computer Model
6%
Enzyme
6%
Histone Deacetylase
6%
Mitochondrion
6%
Cell Death
6%
Androgen Receptor
6%
Small Interfering RNA
6%
Genetic Polymorphism
5%
Transcription
5%
Synapsin I
5%
Allele
5%
Glucose-Regulated Protein
5%
Genetic Divergence
5%
Proteomics
5%
Cell Invasion
5%
IC50
5%
Long Non-Coding RNA
5%
Gene Polymorphism
5%
Surface Property
5%
Metabolic Pathway
5%
STAT3
5%
Estrogen Receptor
5%
Microarrays
5%
Gene Signature
5%
Tumor Suppressor Protein
5%